OBJECTIVES: To evaluate prospectively four rapid, point-of-care serological tests for syphilis in prenatal or high risk populations in four countries. METHODS: Tests were performed on consecutive clinic attenders, using whole blood in the clinic, and whole blood and serum in the laboratory. The sensitivity and specificity of each test was evaluated, using a standard treponemal test (Treponema pallidum haemagglutination assay (TPHA) or fluorescent treponemal antibody, absorbed (FTA-ABS) as gold standard. Non-treponemal tests (rapid plasma reagin (RPR) or venereal diseases research laboratory (VDRL) tests) were also performed on all subjects at three sites. RESULTS: The specificity of each rapid test was >95% at each site. Sensitivities varied from 64-100% and, in most cases, were lower when whole blood was used rather than serum. CONCLUSIONS: Rapid serological tests for syphilis are an acceptable alternative to conventional laboratory tests. Since they do not require equipment or electricity, they could increase coverage of syphilis screening, and enable treatment to be given at the first clinic visit.
OBJECTIVES: To evaluate prospectively four rapid, point-of-care serological tests for syphilis in prenatal or high risk populations in four countries. METHODS: Tests were performed on consecutive clinic attenders, using whole blood in the clinic, and whole blood and serum in the laboratory. The sensitivity and specificity of each test was evaluated, using a standard treponemal test (Treponema pallidum haemagglutination assay (TPHA) or fluorescent treponemal antibody, absorbed (FTA-ABS) as gold standard. Non-treponemal tests (rapid plasma reagin (RPR) or venereal diseases research laboratory (VDRL) tests) were also performed on all subjects at three sites. RESULTS: The specificity of each rapid test was >95% at each site. Sensitivities varied from 64-100% and, in most cases, were lower when whole blood was used rather than serum. CONCLUSIONS: Rapid serological tests for syphilis are an acceptable alternative to conventional laboratory tests. Since they do not require equipment or electricity, they could increase coverage of syphilis screening, and enable treatment to be given at the first clinic visit.
Authors: M Temmerman; K Fonck; F Bashir; I Inion; J O Ndinya-Achola; J Bwayo; P Kirui; P Claeys; L Fransen Journal: Int J STD AIDS Date: 1999-06 Impact factor: 1.359
Authors: A J Herring; R C Ballard; V Pope; R A Adegbola; J Changalucha; D W Fitzgerald; E W Hook; A Kubanova; S Mananwatte; J W Pape; A W Sturm; B West; Y P Yin; R W Peeling Journal: Sex Transm Infect Date: 2006-11-21 Impact factor: 3.519
Authors: A Shakarishvili; L K Dubovskaya; L S Zohrabyan; J S St Lawrence; S O Aral; L G Dugasheva; S A Okan; J S Lewis; K A Parker; C A Ryan Journal: Lancet Date: 2005 Jul 2-8 Impact factor: 79.321
Authors: K L Southwick; S Blanco; A Santander; M Estenssoro; F Torrico; G Seoane; W Brady; M Fears; J Lewis; V Pope; J Guarner; W C Levine Journal: Bull World Health Organ Date: 2003-11-05 Impact factor: 9.408
Authors: Joseph D Tucker; Sarah J Hawkes; Yue-Pin Yin; Rosanna W Peeling; Myron S Cohen; Xiang-Sheng Chen Journal: Bull World Health Organ Date: 2010-06 Impact factor: 9.408
Authors: P E Campos; A L Buffardi; M Chiappe; C Buendía; P J Garcia; C P Carcamo; G Garnett; P White; K K Holmes Journal: Sex Transm Infect Date: 2006-11-20 Impact factor: 3.519
Authors: Lara E Pereira; Joshua McCormick; Tandin Dorji; Joseph Kang; Yongcheng Sun; Mayur Shukla; Andre Hopkins; John Deutsch; Ellen N Kersh; Kyle Bernstein; Yetunde F Fakile Journal: J Clin Microbiol Date: 2018-09-25 Impact factor: 5.948